Model DetailsLung adenoma
Model Name |
Lung adenoma | Strain |
A/J |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
lung adenoma • lung bronchioalveolar adenoma • bronchioalveolar adenoma • lung bronchoalveolar adenoma • pulmonary adenoma • lung alveolar/bronchiolar adenoma • lung pulmonary adenoma • broncho-alveolar adenoma • lung tumor • lung tumor adenoma • brochoalveolar adenoma • pulmonary adenocarcinoma |
Strain Synonyms |
A • A/J-Jax • Strain A • A/J, H-2a • A/Lilly • A/Jax • AJ • strain A • A/Cloudman |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Lung | Male |
observed |
~65 weeks |
|
Groch KM, Int J Radiat Biol 1997 Mar;71(3):301-8 |
| Lung | Male |
4.3% (1 of 23 mice) |
24 weeks |
|
Bai F, Mol Carcinog 1998 Aug;22(4):258-64 |
| Lung | Male |
31% (9 of 29 mice) |
31-33 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):87-92 |
| Lung | Male |
10% (1 of 10 mice) |
28-30 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
30% (3 of 10 mice) |
28-30 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
40% (4 of 10 mice) |
28-30 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
10% (1 of 10 mice) |
28-30 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
20% (2 of 10 mice) |
28-30 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
30% (3 of 10 mice) |
28-30 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
40% (4 of 10 mice) |
28-30 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
80% |
53-55 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
63% (12 of 19 mice) |
53-55 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
58% (11 of 19 mice) |
53-55 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
68% (13 of 19 mice) |
53-55 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
63% (12 of 19 mice) |
53-55 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
47% (8 of 17 mice) |
53-55 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
64% (16 of 25 mice) |
53-55 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
68% (13 of 19 mice) |
53-55 weeks |
|
McNeill DA, Drug Chem Toxicol 1990;13(1):71-86 |
| Lung | Male |
50% (15 of 30 mice) |
9.5-10 months |
|
Prahalad AK, Carcinogenesis 1997 Oct;18(10):1955-63 |
| Lung | Male |
observed |
13 months |
|
Bauer AK, Carcinogenesis 2000 Apr;21(4):543-50 |
| Lung | Female |
27% (6 of 22 mice) |
32 weeks |
|
Rioux N, Cancer Res 1998 Dec 1;58(23):5354-60 |
| Lung | Female |
25% (5 of 20 mice) |
10 months |
|
D'Agostini F, Int J Oncol 2001 Mar;18(3):607-15 |
| Lung | Mixed Population |
25% (5 of 20 mice) |
~26 weeks |
|
Chen B, Carcinogenesis 1994 Sep;15(9):2031-5 |
| Lung | Mixed Population |
42% (8 of 19 mice) |
~26 weeks |
|
Chen B, Carcinogenesis 1994 Sep;15(9):2031-5 |
| Lung | Female |
20% (4 of 20 mice) |
33 weeks |
|
Prokopczyk B, Cancer Lett 2000 Dec 8;161(1):35-46 |
| Lung | Unspecified |
30% (3 of 10 mice) |
26-27 weeks |
|
Carlton PS, Cancer Lett 2000 Oct 31;159(2):113-7 |
| Lung | Unspecified |
50% (10 of 20 mice) |
26-27 weeks |
|
Carlton PS, Cancer Lett 2000 Oct 31;159(2):113-7 |
| Lung | Unspecified |
11% (1 of 9 mice) |
30-31 weeks |
|
Carlton PS, Cancer Lett 2000 Oct 31;159(2):113-7 |
| Lung | Unspecified |
20% (4 of 20 mice) |
30-31 weeks |
|
Carlton PS, Cancer Lett 2000 Oct 31;159(2):113-7 |
| Lung | Female |
0% (0 of 15 mice) |
22 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Mixed Population |
3.2% (1 of 31 mice) |
9 weeks |
|
Kim SH, Anticancer Res 1996 Jan-Feb;16(1):465-70 |
| Lung | Female |
11% |
33-34 weeks |
|
Wang ZY, Cancer Res 1992 Apr 1;52(7):1943-7 |
| Lung | Female |
10% (3 of 30 mice) |
31-32 weeks |
|
Wang ZY, Cancer Res 1992 Apr 1;52(7):1943-7 |
| Lung | Female |
4.0% (1 of 25 mice) |
23-24 weeks |
|
Wang ZY, Cancer Res 1992 Apr 1;52(7):1943-7 |
| Lung | Female |
20% (2 of 10 mice) |
31-32 weeks |
|
Duperron C, Carcinogenesis 1997 May;18(5):1001-6 |
| Lung | Male |
observed |
620 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Male |
observed |
638 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Male |
observed |
399 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Female |
observed |
|
Gordon T, Cancer Lett 2009 Mar 18;275(2):213-20 | |
| Lung | Female |
observed |
536 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Female |
observed |
527 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Female |
observed |
740 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Female |
observed |
718 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Male |
observed |
619 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Male |
observed |
619 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Male |
observed |
619 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Male |
observed |
619 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Male |
observed |
619 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Female |
observed |
620 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Female |
observed |
695 days |
|
Sundberg J, MGI Direct Data Submission 2007;(): |
| Lung | Female |
28.57% (2 of 7 mice) |
20 months |
|
Berndt A, Cancer Res 2011 Sep 1;71(17):5779-91 |
| Lung | Male |
66.67% (6 of 9 mice) |
20 months |
|
Berndt A, Cancer Res 2011 Sep 1;71(17):5779-91 |
| Lung | Female |
moderate |
20 months |
|
Sundberg JP, Pathobiol Aging Age Relat Dis 2011;1(): |
| Lung | Female |
high |
20 months |
|
Sundberg JP, Pathobiol Aging Age Relat Dis 2011;1(): |
![](\"/mtbwi/live/www/img/pic.gif\")